MDS Pharma has appointed Nils Hoem as director of pharmacokinetics/pharmacodynamics in Europe, the company said last week.
Hoem will be responsible for managing a team of approximately 15 scientists located in MDS’ European clinical pharmacology units. Prior to joining MDS, Hoem ran his own business, Hoem Pharma Consulting. He was also employed by Smerud Medical Research Group and the University of Oslo. He holds a PhD in clinical pharmacokinetics and pharmacodynamics from the University of Oslo.
Millipore announced last week that its new president and CEO, Martin Maduas, will start on Jan. 1, 2005. He will also join Millipore’s board of directors at that time. Maduas is assuming the roles of president and CEO from Francis Lunger, who will remain as chairman of the board until March 1, 2005, Millipore said.
Philip Petraglia has become controller of the Pittsburgh Life Sciences Greenhouse, PLSG said last week. He joins the public/private biotech investment partnership from Resources Connection, a professional services firm. Petraglia holds a bachelor’s degree from Westminster College in New Wilmington, Pa.